# Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV

> **NCT03931083** · — · UNKNOWN · sponsor: **University of Bern** · enrollment: 450 (estimated)

## Conditions studied

- Uterine Cervical Neoplasms
- HIV/AIDS

## Interventions

- **DIAGNOSTIC_TEST:** Screening for CIN2+/HSIL

## Key facts

- **NCT ID:** NCT03931083
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-08
- **Primary completion:** 2021-01-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2020-11-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03931083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03931083, "Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03931083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*